Dr. Deep Vora

Oncologist & Hemato-Oncologist, Immuno-Oncologist

DNB Internal Medicine, DM Medical Oncology, MRCP SCE (UK) | ESMO Certified, Certification in Advanced Oncology (Harvard Medical School)

Dr. Deep Vora is a dedicated Medical Oncologist, Hemato-Oncologist, and Immuno-Oncologist with over 4 years of specialised experience in the management of both solid tumors and hematological malignancies. He is known for delivering evidence-based, precision-driven, and compassionate cancer care, supported by strong academic training and hands-on experience at premier oncology institutions. Dr. Vora has received advanced oncology training at Tata Memorial Hospital, Parel, and ACTREC (Advanced Centre for Treatment, Research and Education in Cancer). During his tenure at ACTREC, he gained hands-on experience in Bone Marrow Transplantation (BMT) and the management of complex hematological cancers, ensuring comprehensive and multidisciplinary cancer treatment. Academically, Dr. Vora holds an MBBS degree from Smt. NHL Municipal Medical College, followed by a DNB in Internal Medicine from P.D. Hinduja Hospital, one of India’s most respected tertiary care centres. He then completed his DM in Medical Oncology from Tata Memorial Hospital, India’s apex cancer institute. Additionally, he has cleared the MRCP SCE (UK) examination and is certified by the European Society of Medical Oncology (ESMO), reflecting alignment with global oncology standards. Dr. Vora further strengthened his expertise by completing a Certification in Advanced Oncology from Harvard Medical School, Boston. This exposure provided him with a strong foundation in modern oncology practices, precision oncology, molecular targeted therapies, and immuno-oncology. A distinguished academic performer, Dr. Deep Vora secured All India Rank 8 in the DM Medical Oncology Entrance Examination at Tata Memorial Centre, a significant achievement highlighting his dedication, academic excellence, and commitment to advancing cancer care. Clinically, Dr. Vora specializes in solid tumors, hematological malignancies, precision oncology, molecular targeted therapies, and immunotherapy. He also has a special interest in geriatric oncology, focusing on individualized treatment approaches for elderly cancer patients. In addition to clinical practice, Dr. Vora is actively involved in oncology research. He has published papers on breast cancer treatment, COVID-19 vaccine uptake in cancer patients, and esophageal cancer. He has also co-authored research on lung cancer therapies, contributing to evidence-based oncology practice and advancements in patient care. Dr. Vora is widely appreciated for his patient-centric approach, clear communication, and commitment to ethical oncology practice. His goal is to provide personalised, advanced, and compassionate cancer treatment that prioritises both clinical outcomes and quality of life.

My approach to cancer care is grounded in scientific precision, empathy, and evidence-based medicine. I believe in personalised oncology treatment guided by tumour biology, molecular profiling, and global clinical guidelines. Transparent communication and compassionate care remain central to supporting patients and their families throughout the cancer journey.